Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters

J Clin Oncol. 2009 Nov 9; Epub ahead of print, HR Alexander Jr, DL Fraker, DL Bartlett, SK Libutti, SM Steinberg, P Soriano, T Beresnev

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

A significant proportion of patients with melanoma will develop regionally advanced disease of the extremity. Isolated limb perfusion (ILP) is a surgical procedure that delivers systemic therapy intravascularly to the affected region. ILP has the advantage of delivering higher regional drug concentrations while limiting the toxicity from systemic administration. However, although ILP has been used for treatment of in-transit extremity melanoma for several decades, it is has not gained widespread...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration